Literature DB >> 11337378

Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids.

S Kytölä1, A Höög, B Nord, B Cedermark, T Frisk, C Larsson, M Kjellman.   

Abstract

Carcinoid tumors are rare neuroendocrine tumors occurring in the lung or in the digestive tract where they are further subclassified as foregut, midgut, or hindgut carcinoids. To gain a better understanding of the genetic basis of the different types of carcinoid tumors, we have characterized numerical imbalances in a series of midgut carcinoids, and compared the results to previous findings in carcinoids from the lung. Numerical imbalances were revealed in 16 of the 18 tumors, and the most commonly detected aberrations were losses of 18q22-qter (67%), 11q22-q23 (33%), and 16q21-qter (22%), and gain of 4p14-qter (22%). The total number of alterations found in the metastases was significantly higher than in the primary tumors, indicating the accumulation of acquired genetic changes in the tumor progression. Losses of 18q and 11q were present both in primary tumors and metastases, whereas loss of 16q and gain of 4 were only detected in metastases. Furthermore, the pattern of comparative genomic hybridization alterations varied depending on the total number of detected alterations. Taken together, the findings would suggest a progression of numerical imbalances, in which loss of 18q and 11q represent early events, and loss of 16q and gain of 4p are late events in the tumor progression of midgut carcinoids. When compared to previously published comparative genomic hybridization abnormalities in lung carcinoids, loss of 11q was found to occur in both tumor types, whereas loss of 18q and 16q and gain of 4 were not revealed in lung carcinoids. The results indicate that inactivation of a putative tumor suppressor gene in 18q22-qter represents a frequent and early event that is specific for the development of midgut carcinoids.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337378      PMCID: PMC1891959          DOI: 10.1016/S0002-9440(10)64136-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

1.  A human gene (DDX10) encoding a putative DEAD-box RNA helicase at 11q22-q23.

Authors:  K Savitsky; Y Ziv; A Bar-Shira; S Gilad; D A Tagle; S Smith; T Uziel; S Sfez; J Nahmias; A Sartiel; R L Eddy; T B Shows; F S Collins; Y Shiloh; G Rotman
Journal:  Genomics       Date:  1996-04-15       Impact factor: 5.736

2.  Positional cloning of the gene for multiple endocrine neoplasia-type 1.

Authors:  S C Chandrasekharappa; S C Guru; P Manickam; S E Olufemi; F S Collins; M R Emmert-Buck; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; J S Crabtree; Y Wang; B A Roe; J Weisemann; M S Boguski; S K Agarwal; M B Kester; Y S Kim; C Heppner; Q Dong; A M Spiegel; A L Burns; S J Marx
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

3.  Carcinoid tumors frequently display genetic abnormalities involving chromosome 11.

Authors:  O Jakobovitz; D Nass; L DeMarco; A J Barbosa; F B Simoni; G Rechavi; E Friedman
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

4.  MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma.

Authors:  K Eppert; S W Scherer; H Ozcelik; R Pirone; P Hoodless; H Kim; L C Tsui; B Bapat; S Gallinger; I L Andrulis; G H Thomsen; J L Wrana; L Attisano
Journal:  Cell       Date:  1996-08-23       Impact factor: 41.582

5.  Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors.

Authors:  T Ried; R Knutzen; R Steinbeck; H Blegen; E Schröck; K Heselmeyer; S du Manoir; G Auer
Journal:  Genes Chromosomes Cancer       Date:  1996-04       Impact factor: 5.006

6.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

7.  Involvement of the ALL-1 gene in a solid tumor.

Authors:  R Baffa; M Negrini; S A Schichman; K Huebner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

8.  Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix.

Authors:  K Heselmeyer; E Schröck; S du Manoir; H Blegen; K Shah; R Steinbeck; G Auer; T Ried
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

9.  Genetic aberrations in adrenocortical tumors detected using comparative genomic hybridization correlate with tumor size and malignancy.

Authors:  M Kjellman; O P Kallioniemi; R Karhu; A Höög; L O Farnebo; G Auer; C Larsson; M Bäckdahl
Journal:  Cancer Res       Date:  1996-09-15       Impact factor: 12.701

Review 10.  DCC: linking tumor suppressor genes and altered cell surface interactions in cancer?

Authors:  K R Cho; E R Fearon
Journal:  Curr Opin Genet Dev       Date:  1995-02       Impact factor: 5.578

View more
  27 in total

Review 1.  The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors.

Authors:  Simon Schimmack; Bernhard Svejda; Benjamin Lawrence; Mark Kidd; Irvin M Modlin
Journal:  Langenbecks Arch Surg       Date:  2011-01-28       Impact factor: 3.445

Review 2.  Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies.

Authors:  Gitta Boons; Timon Vandamme; Marc Peeters; Guy Van Camp; Ken Op de Beeck
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

Review 3.  Towards a new classification of gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Mark Kidd; Irvin Modlin; Kjell Öberg
Journal:  Nat Rev Clin Oncol       Date:  2016-06-07       Impact factor: 66.675

4.  Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer-related death after resection.

Authors:  Christina L Roland; Lee F Starker; Y Kang; Deyali Chatterjee; Jeannelyn Estrella; Asif Rashid; Matthew H Katz; Thomas A Aloia; Jeffrey E Lee; Arvind Dasari; James C Yao; Jason B Fleming
Journal:  Surgery       Date:  2016-11-03       Impact factor: 3.982

5.  Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastases.

Authors:  Nicole Posorski; Daniel Kaemmerer; Guenther Ernst; Patricia Grabowski; Dieter Hoersch; Merten Hommann; Ferdinand von Eggeling
Journal:  Clin Exp Metastasis       Date:  2011-06-17       Impact factor: 5.150

Review 6.  Criteria for malignancy in gastrointestinal endocrine tumors.

Authors:  Cesare Bordi; Tiziana D'Adda; Cinzia Azzoni; Silvia Pizzi; Lorena Bottarelli; Francesca Mormandi; Tommaso Antonetti; Tu Vinh Luong; Guido Rindi
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

7.  Carcinoid and neuroendocrine tumors of the colon and rectum.

Authors:  T Philip Chung; Steven R Hunt
Journal:  Clin Colon Rectal Surg       Date:  2006-05

8.  Analysis of chromosome-11 aberrations in pulmonary and gastrointestinal carcinoids: an array comparative genomic hybridization-based study.

Authors:  Susanna Petzmann; Reinhard Ullmann; Iris Halbwedl; Helmut H Popper
Journal:  Virchows Arch       Date:  2004-07-03       Impact factor: 4.064

9.  Gastrin releasing peptide and gastrin releasing peptide receptor expression in gastrointestinal carcinoid tumours.

Authors:  N Scott; E Millward; E J Cartwright; S R Preston; P L Coletta
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

Review 10.  The epidemiology and pathogenesis of neoplasia in the small intestine.

Authors:  David Schottenfeld; Jennifer L Beebe-Dimmer; Fawn D Vigneau
Journal:  Ann Epidemiol       Date:  2009-01       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.